Table 3.
Women’s contraceptive use status after discontinuation of baseline method, by selected characteristics, Honduras, 2006–2007; N=273
| Independent variables assessed at baseline | Switched N=117 % |
Discontinued N=156 % |
||
|---|---|---|---|---|
| Demographic characteristics | ||||
| Age** | ||||
| 15–24 | 58.1 | 43.0 | ||
| 25–34 | 37.6 | 47.4 | ||
| 35–44 | 4.3 | 9.6 | ||
| Education** | ||||
| None | 3.4 | 7.0 | ||
| Primary | 57.3 | 68.6 | ||
| Secondary+ | 39.3 | 24.4 | ||
| Parity** | ||||
| 0–1 | 54.7 | 42.3 | ||
| 2+ | 45.3 | 57.7 | ||
| Union Status** | ||||
| In union | 89.7 | 80.1 | ||
| Not in union | 10.3 | 19.9 | ||
| Residence*** | ||||
| Rural | 16.2 | 32.0 | ||
| Urban | 83.8 | 68.0 | ||
| Monthly household income | ||||
| Lower | 45.3 | 55.1 | ||
| Middle | 29.9 | 25.0 | ||
| Higher | 24.8 | 19.9 | ||
| Fertility desires | ||||
| Fertility desires*** | ||||
| Desire another child < 2 years | 6.8 | 19.2 | ||
| Desire another child > 2 years or DK when | 55.6 | 39.1 | ||
| Desires no more children | 28.2 | 35.9 | ||
| Undecided | 9.4 | 5.6 | ||
| Service quality | ||||
| Had all questions answered by provider*** | 72.7 | 50.0 | ||
| Received info. on how to use method effectively | 52.1 | 43.6 | ||
| Received info. on advantages/disadvantages of method* | 44.4 | 34.6 | ||
| Ever informed about side effects of their method | 69.2 | 65.4 | ||
| Method characteristics | ||||
| Length of use at baseline*** | ||||
| Used method >1 year | 15.4 | 36.5 | ||
| Used method ≤1 year | 23.1 | 16.7 | ||
| New to method | 61.5 | 46.8 | ||
| Method used at baseline** | ||||
| IUD | 20.5 | 9.6 | ||
| Injectable | 73.5 | 80.8 | ||
| Pills | 6.0 | 9.6 | ||
| Experience with side effects | ||||
| Had side effects during study period*** | 89.7 | 69.9 | ||
| Had 2 or more side effects during study period*** | 60.7 | 41.7 | ||
| Type of side effect experienced | ||||
| Abdominal pain*** | 23.9 | 11.5 | ||
| Amenorrhea* | 18.8 | 28.2 | ||
| Dizziness | 18.8 | 18.6 | ||
| Headaches | 30.8 | 29.5 | ||
| Heavy bleeding** | 30.8 | 18.0 | ||
| Weight gain | 20.5 | 14.1 | ||
| Felt side effects interfered with daily activities*** | 54.7 | 35.3 | ||
| Felt side effects interfered with relationship with partner*** | 41.0 | 23.7 | ||
| Self-medicated or took home remedies | 23.1 | 20.5 | ||
| Sought help from a clinic or health worker*** | 55.6 | 28.2 | ||
| Communication with others | ||||
| Discussed side effects with 2 or more people*** | 57.3 | 32.1 | ||
| Discussed side effects with partner*** | 63.3 | 37.2 | ||
| Discussed side effects with family member(s) | 35.0 | 26.3 | ||
| Discussed side effects with friends* | 18.0 | 10.9 | ||
| Discussed side effects with health worker*** | 48.8 | 26.9 | ||
| Discussed stopping BL method with partner before making decision to discontinue*** | 86.3 | 60.3 | ||
| Main reason for discontinuation of BL method*** | (n=114) | (n=156) | ||
| Reduced need | 3.5 | 44.9 | ||
| Problems with method | 87.7 | 48.7 | ||
| Other | 8.8 | 6.4 |
*
p<0.1;
**
p<0.05;
***
p<0.01